Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA yield is N/A as of 2026-10-06T22:39:00.996Z.
Calculation as of: 2026-10-06T22:39:00.996Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0d3a12511cd932522e29841d112ac79c3666bd2c66ede85cfa79360bad82955a
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EBITDA YIELD
N/A
| NAME | MARKET CAP | EBITDA YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tevogen Bio Holdings Inc. (TVGN) | $27.03M | N/A | N/A | N/A | N/A |
| aTyr Pharma, Inc. (ATYR)vs › | $27.79M | N/A | N/A | N/A | N/A |
| Seres Therapeutics, Inc. (MCRB)vs › | $28.08M | N/A | N/A | N/A | N/A |
| iTonic Holdings Ltd. (ITOC)vs › | $28.10M | N/A | N/A | N/A | N/A |
| OneMedNet Corporation (ONMD)vs › | $28.31M | N/A | N/A | N/A | N/A |
| BeyondSpring Inc. (BYSI)vs › | $28.47M | N/A | N/A | N/A | N/A |
| ABVC BioPharma, Inc. (ABVC)vs › | $25.22M | N/A | 0.01% | 0.01% | 0.01% |
| Quantum Cyber N.V. (QUCY)vs › | $29.37M | N/A | N/A | N/A | N/A |
| InspireMD, Inc. (NSPR)vs › | $24.60M | N/A | N/A | N/A | N/A |
| Context Therapeutics Inc. (CNTX)vs › | $29.57M | N/A | N/A | N/A | N/A |
EBITDA Yield = TTM EBITDA / Enterprise Value
EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute